Drug Modeling Software Market to Grow at a CAGR of 8.1% to reach US$ 6,205.22 Million from 2020 to 2027

    Drug Modeling Software Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product type ( Database, Software, Others ); Application ( Drug Discovery and Development, Computational Physiological Medicine, Disease Modeling, Medical Imaging, Predictive Analysis of Drug Targets, Simulation Software, Cellular Simulation ), and Geography

    Publication Month: Aug 2020 | Report Code: TIPRE00013619 | No. of Pages: 156 | Category: Healthcare IT | Status: Published

    The drug modeling software market was valued at US$ 6,205.22 million in 2019 and is projected to reach US$ 11,299.85 million by 2027; it is expected to grow at a CAGR of 8.1% from 2020 to 2027.

    Drug modeling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing a key role in the development of novel drugs. Software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction, and molecular dynamics are considered to be powerful tool for the investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. Additionally, appropriate implementation of these techniques may help in reducing drug designing and development cost. Increasing cost of the drug development coupled with increasing drug failures is likely to drive the growth of the drug modeling software market during the forecast period. However, the market is likely to get negatively impacted by the less adoption of drug modeling software in emerging countries.

    Lucrative Regions for Drug Modeling Software Market
    Lucrative Regions for Drug Modeling Software Market

    Get more information on this report :



    Market Insights

    Increasing Adoption of Modeling Tools in Drug Discovery

    The discovery and development of new drugs with potential therapeutic applications is a complex, expensive, and time-consuming venture. Considering these challenges, various novel technologies have been developed to increase the efficiency of the drug discovery process. Computational methodologies have become a crucial part of several drug discovery programs. From hit identification to lead optimization, techniques such as ligand or structure-based virtual screening are widely being used by many pharmaceutical companies. With the help of modeling, existing data can be leveraged to gain insights on product safety and effectiveness. Owing to the efficiency of computational methods, the FDA and EMA have included modeling to support efficient drug development. Nowadays, in-Silico design (computer-aided) is being utilized to expedite and facilitate hit identification, optimize the absorption, distribution, metabolism, and toxicity profile to avoid safety issues. Commonly used in-silico approaches include ligand-based drug design, structure-based drug design, and quantitative structure-activity.

    These methods are faster and provide valuable insights to experimental findings and mechanisms of action. Moreover, various pharmaceutical companies have started adopting these techniques for better outcomes. For instance, in April 2020, Boehringer Ingelheim has partnered with Insilico Medicine to leverage artificial intelligence (AI) technology to identify potential therapeutic targets. These methods are highly beneficial in case of virus outbark and emergency development of drugs. For instance, in Aug 2020, Certara announced the development of a new biosimulation platform for COVID-19 vaccines. The company has partnered with pharmaceutical companies to speed up the drug discovery and development. Its QSP platforms have vast potential to improve biopharmaceutical research and development and inform decision-making. By creating virtual patients and virtual trials, this new vaccine platform will facilitate dosing strategies for a range of patients infected by COVID-19. Moreover, many research organizations have also started adopting drug modeling technologies for expediting the research process. For instance, Southwest Research Institute (SwRI) is expanding the capacity to virtually screen drug compounds for possible treatment of COVID-19 and other infectious diseases. Recently, SwRI increased the capacity of its Rhodium software to scan 250,000 drug compounds per day. Thus, above mentioned factors are expected to drive the growth of the drug modeling software market during the forecast period.

    Product Type-Based Insights

    Based on product type, the drug modeling software market is segmented into database, software, and others. The software segment held the largest share of the market in 2019. Successful drug discovery, development, and launch of a single new drug into the market, costs about one billion dollars, and it requires nearly 12 years for accomplishing. High cost, insufficient and lengthy-time duration, high level of risk, uncertainty in the results, and highly complex procedures are the main challenges in developing a new drug. To overcome these problems, there is a strong need to employ new and cost-effective drug discovery and designing methods, such as software and computer-aided drug design and molecular docking. For instance, the platform provided by Schrödinger has devoted decades to refining computational algorithms to accurately compute the essential properties of molecules. The company uses NVIDIA GPUs to generate and evaluate the petabytes of data to accelerate drug discovery, as an improvement over the traditional process of slow and expensive lab work.

    Exploring software and model-based tools has become a vital way of drug discovery and development in the pharmaceutical industry, playing a crucial role in expanding new bio-active drugs across a range of therapeutic areas. Proper use of software and computer-based modern methods has reduced several hindrances in drug discovery and hastened new drug development.

    Global Drug Modeling Software Market, by Product Type– 2019 & 2027

    Global Drug Modeling Software Market, by Product Type– 2019 & 2027

    Get more information on this report :


    Application-Based Insights

    Based on application, the drug modeling software market is segmented into drug discovery and development, medical imaging, computational physiological medicine, predictive analysis of drug targets, disease modeling, simulation software, cellular simulation, and others. The drug discovery process is complex and includes an interdisciplinary effort to design practical and commercially feasible drugs. In pharmaceutical, medicinal, and other scientific research, a computer plays a significant role in the development of new compounds in the quest for better therapeutic agents.

    Moreover, computational power along with advanced analytical techniques such as X-ray crystallography and NMR, have improved the application of CADD (Computer-Aided Drug Design) in the field of pharmaceutical industries like numerous of approved drugs that credited their discovery in large part to the tools of CADD, such as angiotensin-converting enzyme (ACE) inhibitor captopril for the treatment of hypertension, Carbonic anhydrase inhibitor dorzolamide for the treatment of cystoid macular edema, renin inhibitor aliskiren, which is used for essential hypertension, Human immunodeficiency virus (HIV) protease inhibitors saquinavir, ritonavir, and indinavir for the treatment of HIV. Moreover, the CADD and bioinformatics tools provide benefits such as cost-saving, time to market, in-sight knowledge of drug-receptor interactions, and speed up drug discovery and development. Such advantages offered by drug modeling software for drug discovery and drug development will drive the segmental growth during the forecast period.

    Additionally, the development of new platforms will further offer lucrative opportunities. For instance, on March 16, 2020, Fujitsu has partnered with Polarisqb to pilot a ground-breaking new drug discovery platform designed to support pharmaceutical companies in bringing vital medication to market quickly and cost-effectively. The platform uses quantum-inspired technology, machine learning, hybrid quantum mechanics, and molecular mechanics simulations (QM/MM) to transform the process of drug discovery. On July 19, 2019, Pumas-AI, a new company established by the University of Maryland School of Pharmacy faculty members, announced its first cutting-edge software platform for pharmaceutical researchers and clinicians, known as Pharmaceutical Modeling and Simulation (Pumas). It is a comprehensive platform based on the Julia programming language that contains multiple modules designed to meet the needs of analysts in the pharmaceutical industry, while also working to advance therapeutic innovation in the clinic setting. In August 2019, London, UK-headquartered Evaluate, a company providing software services for researchers and drug developers, has released Product Specific PTRS (probability of technical and regulatory success), a platform that processes data to predict a drug’s likelihood of success. However, the predictive analysis of drug targets segment is anticipated to witness a significant growth rate during the forecast period.

    Strategic Insights

    Product launches and expansion strategies are commonly adopted by the companies to expand their footprint worldwide, meet the growing demand, and increase its product portfolio.

    The key players operating in the drug modeling software market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.

    By Product Type

    • Database
    • Software
    • Others

    By Application

    • Drug Discovery and Development
    • Computational Physiological Medicine
    • Disease Modeling
    • Medical Imaging
    • Predictive Analysis of Drug Targets
    • Simulation Software
    • Cellular Simulation
    • Others

    By Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • UK
      • Spain
    • Asia Pacific (APAC)
      • China
      • India
      • South Korea
      • Japan
      • Australia
    • Middle East & Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE
    • South and Central America (SCAM)
      • Brazil
      • Argentina

    Company Profiles

    • Crown Bioscience Inc.
    • Chemical Computing Group Ulc
    • Nimbus Therapeutics
    • Schrödinger, Inc.
    • Dassault Systèmes
    • Genedata Ag
    • Biognos Ab
    • Compugen Ltd
    • Acellera ltd.
    • Leadscope, Inc

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Drug Modelling Software Market – By Product Type

    1.3.2 Global Drug Modelling Software Market – By Application

    1.3.3 Global Drug Modelling Software market – By Geography

    2. Drug Modelling Software Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Global Drug Modelling Software Market – Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America – PEST Analysis

    4.2.2 Europe – PEST Analysis

    4.2.3 Asia Pacific – PEST Analysis

    4.2.4 Middle East and Africa (MEA) – PEST Analysis

    4.2.5 South and Central America (SCAM) – PEST Analysis

    4.3 Expert Opinions

    5. Drug Modelling Software Market– Key Market Dynamics

    5.1 Key Market Drivers

    5.1.1 Increasing Adoption of Modelling Tools in Drug Discovery

    5.1.2 Increasing Economic Burden of Drug Discovery

    5.2 Key Market Restraints

    5.2.1 Less Adoption in Emerging Countries

    5.3 Key Market Opportunities

    5.3.1 Strategic Activities by Market Players

    5.4 Future Trends

    5.4.1 Growing Adoption of Artificial Intelligence in Drug Discovery

    5.5 Impact analysis

    6. Drug Modelling Software Market – Global Analysis

    6.1 Global Drug Modelling Software Market Revenue Forecast And Analysis

    6.2 Global Drug Modelling Software Market, By Geography - Forecast And Analysis

    6.3 Market Positioning of Key Players

    7. Drug Modelling Software Market – By Product Type

    7.1 Overview

    7.2 Drug Modelling Software Market, by Product Type, 2019 and 2027 (%)

    7.3 Database

    7.3.1 Overview

    7.3.2 Database: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    7.5 Software

    7.5.1 Overview

    7.5.2 Software: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    7.6 Other Product Types

    7.6.1 Overview

    7.6.2 Other Product Types: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    8. Drug Modelling Software Market Analysis – By Application

    8.1 Overview

    8.2 Drug Modelling Software Market Revenue Share, by Application (2019 and 2027)

    8.3 Drug Discovery and Development

    8.3.1 Overview

    8.3.2 Drug Discovery and Development: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    8.4 Computational Physiological Medicine

    8.4.1 Overview

    8.4.2 Computational Physiological Medicine: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    8.5 Disease Modelling

    8.5.1 Overview

    8.5.2 Disease Modelling: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    8.6 Medical Imaging

    8.6.1 Overview

    8.6.2 Medical Imaging: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    8.7 Predictive Analysis of Drug Targets

    8.7.1 Overview

    8.7.2 Predictive Analysis of Drug Targets: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    8.8 Simulation Software

    8.8.1 Overview

    8.8.2 Simulation Software: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    8.9 Cellular Simulation

    8.9.1 Overview

    8.9.2 Cellular Simulation: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    8.10 Others

    8.10.1 Overview

    8.10.2 Others: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    9. Drug Modelling Software Market Analysis And Forecasts To 2027 – Geographical Analysis

    9.1 North America: Drug Modelling Software Market

    9.1.1 Overview

    9.1.2 North America: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.1.3 North America: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.1.4 North America: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.1.5 North America: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

    9.1.6 US: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.1.6.1 US: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.1.6.2 US: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.1.6.3 US: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.1.7 Canada: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.1.7.1 Canada: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.1.7.2 Canada: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.1.7.3 Canada: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.1.8 Mexico: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.1.8.1 Mexico: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.1.8.2 Mexico: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.1.8.3 Mexico: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.1.9 North America: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

    9.2 Europe: Drug Modelling Software Market

    9.2.1 Overview

    9.2.2 Europe: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.2.3 Europe: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.2.4 Europe: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.2.5 Europe: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

    9.2.6 Germany: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.2.6.1 Germany: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.2.6.2 Germany: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.2.6.3 Germany: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.2.7 France: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.2.7.1 France: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.2.7.2 France: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.2.7.3 France: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.2.8 UK: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.2.8.1 UK: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.2.8.2 UK: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.2.8.3 UK: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.2.9 Italy: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.2.9.1 Italy: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.2.9.2 Italy: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.2.9.3 Italy: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.2.10 Spain: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.2.10.1 Spain: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.2.10.2 Spain: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.2.10.3 Spain: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.3 Asia-Pacific: Drug Modelling Software Market

    9.3.1 Overview

    9.3.2 Asia-Pacific: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)

    9.3.3 Asia-Pacific Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.3.4 Asia-Pacific Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.3.5 Asia-Pacific: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

    9.4.1 China: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.4.1.1 China: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.4.1.2 China Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.4.1.3 China Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.4.2 Japan: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.4.2.1 Japan: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.4.2.2 Japan Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.4.2.3 Japan Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.4.3 India: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.4.3.1 India: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.4.3.2 India Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.4.3.3 India Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.4.4 South Korea: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.4.4.1 South Korea: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.4.4.2 South Korea Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.4.4.3 South Korea Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.4.5 Australia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.4.5.1 Australia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.4.5.2 Australia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.4.5.3 Australia Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.5 Middle East & Africa: Drug Modelling Software Market

    9.5.1 Overview

    9.5.2 Middle East & Africa: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)

    9.5.3 Middle East & Africa Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

    9.5.4 Middle East & Africa Drug Modelling Software Market, by Application– Revenue and Forecast to 2027 (USD Million)

    9.5.5 Middle East & Africa: Drug Modelling Software Market, by Country, 2018 & 2027 (%)

    9.5.6 Saudi Arabia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.5.6.1 Saudi Arabia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.5.6.2 Saudi Arabia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.5.6.3 Saudi Arabia Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.5.7 UAE: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.5.7.1 UAE: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.5.7.2 UAE Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

    9.5.7.3 UAE Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

    9.5.8 South Africa: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.5.8.1 South Africa: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.5.8.2 South Africa Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.5.8.3 South Africa Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.6 South and Central America: Drug Modelling Software Market

    9.6.1 Overview

    9.6.2 South and Central America: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.6.3 South and Central America Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.6.4 South and Central America Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.6.5 South and Central America: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

    9.6.6 Brazil: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.6.6.1 Brazil: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.6.6.2 Brazil Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.6.6.3 Brazil Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    9.6.7 Argentina: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.6.7.1 Argentina: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    9.6.7.2 Argentina Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    9.6.7.3 Argentina Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    10. Impact Of COVID-19 Pandemic On Global Drug Modelling Software Market

    10.1 North America: Impact Assessment of COVID-19 Pandemic

    10.2 Europe: Impact Assessment Of COVID-19 Pandemic

    10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

    11. Drug Modelling Software Market – Industry Landscape

    11.1 Overview

    11.2 Growth Strategies Done by the Companies in the Market, (%)

    11.3 Organic Developments

    11.3.1 Overview

    11.4 Inorganic Developments

    11.4.1 Overview

    12. Company Profiles

    12.1 Crown Bioscience Inc (JSR life science)

    12.1.1 Key Facts

    12.1.2 Business Description

    12.1.3 Products and Services

    12.1.4 Financial Overview

    12.1.5 SWOT Analysis

    12.1.6 Key Developments

    12.2 Chemical Computing Group ULC.

    12.2.1 Key Facts

    12.2.2 Business Description

    12.2.3 Products and Services

    12.2.4 Financial Overview

    12.2.5 SWOT Analysis

    12.2.6 Key Developments

    12.3 Nimbus Therapeutics

    12.3.1 Key Facts

    12.3.2 Business Description

    12.3.3 Products and Services

    12.3.4 Financial Overview

    12.3.5 SWOT Analysis

    12.3.6 Key Developments

    12.4 Schrödinger, Inc.

    12.4.1 Key Facts

    12.4.2 Business Description

    12.4.3 Products and Services

    12.4.4 Financial Overview

    12.4.5 SWOT Analysis

    12.4.6 Key Developments

    12.5 Genedata AG

    12.5.1 Key Facts

    12.5.2 Business Description

    12.5.3 Products and Services

    12.5.4 Financial Overview

    12.5.5 SWOT Analysis

    12.5.6 Key Developments

    12.6 Biognos AB

    12.6.1 Key Facts

    12.6.2 Business Description

    12.6.3 Products and Services

    12.6.4 Financial Overview

    12.6.5 SWOT Analysis

    12.6.6 Key Developments

    12.7 Compugen Ltd.

    12.7.1 Key Facts

    12.7.2 Business Description

    12.7.3 Products and Services

    12.7.4 Financial Overview

    12.7.5 SWOT Analysis

    12.7.6 Key Developments

    12.8 Dassault Systèmes

    12.8.1 Key Facts

    12.8.2 Business Description

    12.8.3 Products and Services

    12.8.4 Financial Overview

    12.8.5 SWOT Analysis

    12.8.6 Key Developments

    12.9 Acellera

    12.9.1 Key Facts

    12.9.2 Business Description

    12.9.3 Products and Services

    12.9.4 Financial Overview

    12.9.5 SWOT Analysis

    12.10 Leadscope, Inc (Instem)

    12.10.1 Key Facts

    12.10.2 Business Description

    12.10.3 Products and Services

    12.10.4 Financial Overview

    12.10.5 SWOT Analysis

    12.10.6 Key Developments

    13. Appendix

    13.1 About The Insight Partners

    13.2 Glossary of Terms

    LIST OF TABLES

    Table 1. North America: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 2. North America: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 3. US: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 4. US: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 5. Canada: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 6. Canada: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 7. Mexico: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 8. Mexico: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 9. Europe: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 10. Europe: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 11. Germany: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 12. Germany: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 13. France: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 14. France: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 15. UK: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 16. UK: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 17. Italy: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 18. Italy: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 19. Spain: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 20. Spain: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 21. Asia-Pacific Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 22. Asia-Pacific Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 23. China Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 24. China Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 25. Japan Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 26. Japan Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 27. India Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 28. India Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 29. South Korea Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 30. South Korea Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 31. Australia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 32. Australia Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 33. Middle East & Africa Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

    Table 34. Middle East & Africa Drug Modelling Software Market, by Application– Revenue and Forecast to 2027 (USD Million)

    Table 35. Saudi Arabia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 36. Saudi Arabia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 37. UAE Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

    Table 38. UAE Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 39. South Africa Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 40. South Africa Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 41. South and Central America Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 42. South and Central America Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 43. Brazil Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 44. Brazil Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 45. Argentina Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

    Table 46. Argentina Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

    Table 47. Organic Developments Done By Companies

    Table 48. Inorganic Developments Done By Companies

    Table 49. Glossary of Terms, Drug Modelling Software Market


    LIST OF FIGURES

    Figure 1. Drug Modelling Software Market Segmentation

    Figure 2. Drug Modelling Software Market Segmentation, By Region

    Figure 3. Drug Modelling Software Market Overview

    Figure 4. Software Segment Held Largest Share of Drug Modelling Software Market

    Figure 5. APAC to Show Significant Growth During Forecast Period

    Figure 6. Drug Modelling Software Market, by Geography (US$ Million)

    Figure 7. Global Drug Modelling Software Market – Leading Country Markets (US$ Million)

    Figure 8. Global Drug Modelling Software Market, Industry Landscape

    Figure 9. North America PEST Analysis

    Figure 10. Europe PEST Analysis

    Figure 11. Asia Pacific PEST Analysis

    Figure 12. Middle East and Africa (MEA) PEST Analysis

    Figure 13. South and Central America (SCAM) PEST Analysis

    Figure 14. Drug Modelling Software Market Impact Analysis of Driver and Restraints

    Figure 15. Global Drug Modelling Software Market – Revenue Forecast And Analysis – 2019- 2027

    Figure 16. Market Positioning Of Key Players In Global Drug Modelling Software Market

    Figure 17. Drug Modelling Software Market, by Product Type, 2019 and 2027 (%)

    Figure 18. Database: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 19. Software: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 20. Other Product Types: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 21. Drug Modelling Software Market Revenue Share, by Application (2019 and 2027)

    Figure 22. Drug Discovery and Development: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 23. Computational Physiological Medicine: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 24. Disease Modelling: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 25. Medical Imaging: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 26. Predictive Analysis of Drug Targets: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 27. Simulation Software: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 28. Cellular Simulation: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 29. Others: Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 30. North America: Drug Modelling Software Market, by Key Country – Revenue (2019) (USD Million)

    Figure 31. North America Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)

    Figure 32. North America: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

    Figure 33. US: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 34. Canada: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 35. Mexico: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 36. North America: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

    Figure 37. Europe: Drug Modelling Software Market, by Key Country – Revenue (2019) (USD Million)

    Figure 38. Europe: Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)

    Figure 39. Europe: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

    Figure 40. Germany: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 41. France: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 42. UK: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 43. Italy: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 44. Spain: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 45. Asia-Pacific: Drug Modelling Software Market, by Key Country – Revenue (2019) (USD Million)

    Figure 46. Asia-Pacific Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)

    Figure 47. Asia-Pacific: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

    Figure 48. China: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 49. Japan: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 50. India: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 51. South Korea: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 52. Australia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 53. Middle East & Africa: Drug Modelling Software Market, by Key Country – Revenue (2019) (USD Million)

    Figure 54. Middle East & Africa Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)

    Figure 55. Middle East & Africa: Drug Modelling Software Market, by Country, 2018 & 2027 (%)

    Figure 56. Saudi Arabia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 57. UAE: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 58. South Africa: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 59. South and Central America: Drug Modelling Software Market, by Key Country – Revenue (2019) (USD Million)

    Figure 60. South and Central America Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)

    Figure 61. South and Central America: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

    Figure 62. Brazil: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 63. Argentina: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

    Figure 64. Growth Strategies Done by the Companies in the Market, (%)

    Figure 65. Impact of COVID-19 Pandemic In North American Country Markets

    Figure 66. Impact of COVID-19 Pandemic In European Country Markets

    Figure 67. Impact of COVID-19 Pandemic In Asia Pacific Country Markets

    Figure 68. Impact Of COVID-19 Pandemic In Rest of the World Countries Market

    The List of Companies - Drug Modeling Software Market

    1. Crown Bioscience Inc.
    2. Chemical Computing Group Ulc
    3. Nimbus Therapeutics
    4. Schrödinger, Inc.
    5. Dassault Systèmes
    6. Genedata Ag
    7. Biognos Ab
    8. Compugen Ltd
    9. Acellera ltd.
    10. Leadscope, Inc
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the drug modeling software market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global drug modeling software market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
    TIPRE00013619
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Pricing
    • $2000
    • $4500 $3640
    • $6500 $5240
    • $8500 $6840

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst